Terai S.; Takami T.; Yamamoto N.; Fujisawa K.; Ishikawa T.; Urata Y.; Tanimoto H.; Iwamoto T.; Mizunaga Y.; Matsuda T.; Oono T.; Marumoto M.; Burganova G.; Quintanilha L.; Hidaka I.; Marumoto Y.; Saeki I.; Uchida K.; Yamasaki T.; Tani K.; Taura Y.; Fujii Y.; Nishina H.; Okita K.; Sakaida I.
(2014)
In 2003, we started autologous bone marrow cell infusion (ABMi) therapy for treating liver cirrhosis. ABMi therapy uses 400 mL of autologous bone marrow obtained under general anesthesia and infused mononuclear cells from ...